News

Dec 2024 Paper on CFD Optimization of Micropatterned Surfaces published in Bioengineering.
Nov 2024 Award Awarded the Elxo Graduate Student Scholarship.
Oct 2024 Presented poster on Microfluidic Chip for Disease Modeling at ASCB Conference.
Aug 2024 Started position as Research Associate at University of Pittsburgh.
Jun 2024 Award Won the ASAIO Most Innovative Technologies Award for the Smart Bioprinter project!
May 2024 Joined Zhang Lab at Harvard as Research Intern working on tissue-engineered blood vessels.

Research

Current Research

Blood-Brain Barrier-on-Chip for Cancer Metastasis

University of Pittsburgh · 2024 – Present

Developed a multi-cellular BBB-on-chip model incorporating endothelial cells, pericytes, astrocytes, and neurons. This platform enables real-time visualization of cancer cell extravasation across the blood-brain barrier and screening of therapeutics targeting brain metastasis.

Tissue Engineered Blood Vessels

Harvard University – Zhang Lab · 2024 – 2025

Developing implantable tissue-engineered blood vessels using two-phase bioprinting materials. Created computational models for bidirectional flow dynamics and automated image processing algorithms to characterize cellular responses in vessel-on-chip platforms.

Past Research

Breast Palpation Device for At-Home Tumor Monitoring

Cornell University – Antaki Lab · 2023 – 2024

Engineered a handheld palpation device prototype incorporating optimized optical components and shape-from-shading algorithms for early breast tumor detection. Led SBIR Phase-I and BRCP grant proposals; conducted 40+ stakeholder interviews through NSF I-Corps.

Chromatin Modification Analysis

UPMC Hillman Cancer Center · 2020

Developed a novel clustering approach using Non-Negative Matrix Factorization to analyze twelve histone modifications at forty genomic loci in S. cerevisiae, enabling precise identification of site-specific chromatin signatures in DNA damage response.

Bioinformatics Analysis

Novel Drug Development (DDX3 Inhibitor)

Johns Hopkins University · 2019

Investigated therapeutic efficacy of RK-33, a novel DDX3 pathway inhibitor, for breast and colon cancer treatment. Performed cell viability assays, protein expression profiling via Bradford Assay, Western blots, and single-cell RNA sequencing analysis.

DDX3 Pathway

Bone Regeneration Scaffolds

University of Pittsburgh School of Pharmaceutical Sciences · 2017 – 2018

Built polysaccharide hydrogel beaded scaffolds for bone regeneration. The non-toxic scaffolds were implanted in mice skull models for drug delivery testing. Performed decalcification and storage of mice skulls, created wax blocks using a HistoEmbedder.

Syringe Pump Histo Embedder